HIKMA FDA Approval ANDA 203326

ANDA 203326

HIKMA

FDA Drug Application

Application #203326

Documents

Other2015-07-02

Application Sponsors

ANDA 203326HIKMA

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;SUBLINGUALEQ 2MG BASE;EQ 0.5MG BASE0BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
002TABLET;SUBLINGUALEQ 8MG BASE;EQ 2MG BASE0BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDEBUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2014-06-27
REMS; REMSSUPPL2AP2015-02-12
LABELING; LabelingSUPPL3AP2015-02-04STANDARD
REMS; REMSSUPPL4AP2016-07-07
LABELING; LabelingSUPPL5AP2016-12-16STANDARD
LABELING; LabelingSUPPL6AP2016-12-16STANDARD
REMS; REMSSUPPL7AP2017-05-23
LABELING; LabelingSUPPL10AP2018-02-01STANDARD
REMS; REMSSUPPL11AP2018-10-31
LABELING; LabelingSUPPL14AP2019-10-07STANDARD
LABELING; LabelingSUPPL16AP2021-03-04STANDARD
LABELING; LabelingSUPPL21AP2022-06-14STANDARD
LABELING; LabelingSUPPL23AP2022-06-17STANDARD
REMS; REMSSUPPL24AP2022-05-03
LABELING; LabelingSUPPL25AP2022-06-17STANDARD
REMS; REMSSUPPL27AP2022-12-16

Submissions Property Types

ORIG1Null19
SUPPL2Null15
SUPPL3Null15
SUPPL4Null15
SUPPL5Null7
SUPPL6Null7
SUPPL7Null7
SUPPL10Null15
SUPPL11Null15
SUPPL14Null7
SUPPL16Null7
SUPPL21Null7
SUPPL23Null7
SUPPL24Null7
SUPPL25Null7
SUPPL27Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

HIKMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203326
            [companyName] => HIKMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE","activeIngredients":"BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","strength":"EQ 2MG BASE;EQ 0.5MG BASE","dosageForm":"TABLET;SUBLINGUAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE","activeIngredients":"BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE","strength":"EQ 8MG BASE;EQ 2MG BASE","dosageForm":"TABLET;SUBLINGUAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/27\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"10\/07\/2019","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"10\/31\/2018","submission":"SUPPL-11","supplementCategories":"REMS - MODIFIED - D-N-A","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/01\/2018","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"05\/23\/2017","submission":"SUPPL-7","supplementCategories":"REMS-Modified","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/16\/2016","submission":"SUPPL-6","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"12\/16\/2016","submission":"SUPPL-5","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"07\/07\/2016","submission":"SUPPL-4","supplementCategories":"REMS-Modified","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/04\/2015","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/12\/2015","submission":"SUPPL-2","supplementCategories":"REMS-Proposal","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-10-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.